Saba Shaikh, MD, talks with Thorsten Kühn, PhD, about the AXSANA/EUBREAST 3 study, which showed that, in patients who convert from clinically node-positive to node-negative breast cancer, less invasive surgical staging procedures are associated with a low axillary recurrence rate. These findings reinforce efforts to minimize surgical morbidity without compromising oncologic outcomes.
Estimated Read Time:
1 minute
SABCS Snippets: Results of the AXSANA/EUBREAST 3 Study
Share
Recent Posts
-
December 15, 2025
-
December 15, 2025
-
December 15, 2025
-
December 15, 2025
